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ABSTRACT
Kikuchi-Fujimoto disease, also known as histiocytic necrotizing lymphadenitis of unknown etio-
pathogenesis, is a self-limited disease which frequently appears as feverish lymphadenomegaly, thus 
creating the need for differential diagnosis with lymphoma, systemic lupus erythematosus (SLE), 
infectious mononucleosis, cat-scratch disease, and toxoplasmosis with lymphonodal impairment. 
However, there are cases in which it may evolve with complications such as aseptic meningitis, cer-
ebellar ataxia, and aseptic myocarditis. We are presenting a case of a 24-year-old man who had an 
initial picture of arthralgia, evening fever and adenomegaly. Kikuchi disease was diagnosed through 
lymph node biopsy with immunohistochemistry and evolves with severe systemic manifestations, 
such as pericarditis with cardiac tamponade, pneumonitis, hepatitis, and acute kidney failure - the 
latter has not been reported in literature yet. There was signifi cant improvement of the clinical 
picture with prednisone.
Keywords: Kikuchi-Fujimoto disease; histiocytic necrotizing lymphadenitis; acute renal failure.
[Braz J Infect Dis 2010;14(6):621-627]©Elsevier Editora Ltda.
INTRODUCTION
Kikuchi-Fujimoto Disease (KFD), also known 
as histiocytic necrotizing lymphadenitis, was 
described in Japan, in 1972, by Kikuchi and 
Fujimoto1,2 simultaneously. It is a frequently self-
limited entity, and for that reason it is not often 
diagnosed. It most usually affects women up to 30 
years old. Most cases resolve within six months.3 
The most common symptoms are lymphadenom-
egaly, fever, rash, fatigue, and arthralgia,3 but there 
are reports of cases with severe systemic manifesta-
tions, such as aseptic meningitis, cerebellar ataxia, 
and aseptic myocarditis.4 The histologic fi ndings 
includes areas of coagulation necrosis with abun-
dant karyorrhexis debris. The latter consists of dif-
ferent types of histiocytes, plasmocytes, monocytes, 
immunoblasts, and small and large lymphocytes. 
There is abundant predominance of T lymphocyte 
with prevalent CD8+ in relation to CD4+.11 This 
disease`s pathogenesis is unknown, with autoim-
mune and viral factors implied. It is essential to 
establish a differential diagnosis with lymphoma, 
systemic lupus erythematosus (SLE), infectious 
mononucleosis, cat-scratch disease, and toxoplas-
mosis with lymphonodal impairment.3
The authors report a case with severe 
systemic manifestations, such as hepatosplenom-
egaly, pneumonia, pericardial effusion with cardiac 
tamponade, sepsis, and acute renal failure. The lat-
ter has not been reported in literature yet.
CASE REPORT
Male patient, 24-years-old, black, born in Pi-
auí, coming from Bertioga, SP. He was accepted 
at Santa Casa de Misericórdia de Santos with a 
history of evening fever for 46 days at 38°C, ar-
thralgia in major articulations, myalgia, weight 
loss of 10 kg, anemia, hepatosplenomegaly of 5 
cm and adenomegaly of fi broelastic consistence, 
1 to 2 cm long, in inguinal, axillary, and poste-
rior cervical chains, as well as jaundice +/++++. 
The neck computerized tomography observed 
multiple neck lymph nodes of 1.5 cm in sub-
mentonian and posterior cervical chains. The ab-
dominal ultrasound showed mild hepatomegaly 
and moderate splenomegaly. Results of the blood 
count were: leukocytes 53,900 mm3, platelets
131,000/mm3, red blood cell 3,47 million/mm3,
hemoglobin 7.67 g/dL, hematocrit 24.7%, 
aspartate aminotransferase (AST) 1,208 U/L,
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alanine aminotransferase (ALT) 844 U/L, indirect bilirubin
(IB): 0.38 mg/dL, direct bilirubin (DB): 1.75 mg/dL, 
total bilirubin (TB): 2.13 mg/dL, gamma glutamyl 
transferase (GGT) 542 U/L, as shown in Table 1. 
For the investigation of fever of infectious origin, brucellosis, 
lymphocytes. Several histiocytic cells showed enlarged nu-
cleus with prominent nucleolus. The diagnosis of Hodgkin`s 
lymphoma was excluded by the absence of Reed-Steinberg 
cell and by immunohistochemical examination (negativity of 
immunoexpression for marker CD30).
The histochemical exam of the lymphonodal tissue has 
demonstrated an interfollicular histiocytic and lymphoid 
proliferation with focuses of reactive pattern apoptosis, which 
is coherent with the proliferative phase of histiocytic necrotiz-
ing lymphadenitis, also known as Kikuchi-Fujimoto disease. 
The material was assessed by another pathologist, who con-
fi rmed the diagnosis of Kikuchi-Fujimoto disease through an 
immunohistochemical analysis. Besides the polyclonal aspect, 
the fi nding of lymphocyte CD30 expression was discovered to 
be occasional, with B lymphocyte (CD20) islands, preserved 
lymphoid follicle, and a number of histiocytes (CD68) dif-
fusely distributed (Table 3 and Figures 1 and 2).
In the evolution, the patient showed intense dyspnea, 
and the echocardiogram revealed pericardial effusion with 
cardiac tamponade, which was drained and underwent to 
a biopsy. The anatomopathological examination resulted 
in a mild, non-specifi c, chronic pericarditis. With remis-
sion of symptoms, the patient was discharged from hospital 
three months later. After 75 days, he was readmitted into the 
Service of Infectious Diseases, presenting pneumonia and 
evolution of fever to sepsis. He had fever, hepatosplenom-
egaly, arthralgia, hyperchromic macula-papular skin le-
sions, blurred vision, oral candidiasis, and inguinal and axillary 
adenomegaly of fi broelastic consistence, fi xed and tenderness. 
Blood count: leukocytes 18,000 mm3, platelets 277,000/mm3, 
hemoglobin 11.6 g/dL, hematocrit 35%, red blood cell 
4,95 million/mm3. Lactic dehydrogenase (LDH) 942U/L, al-
kaline phosphatase (AP) 72 UI, AST 107 U/L, ALT 69 U/L, 
GGT 33 U/L, creatinine 0.8 mg/dL, BUN 24 mg/dL, potassium 
(K) 4.9 mEq/L, sodium (Na) 140 mEq/L, albumin 3.2 g/dL, 
as shown in Table 4. In the investigation of autoimmune 
Table 1. Laboratory from the first hospitalization
Red blood cell 3,470 million/mm3
Hemoglobin 7.67 g/dL
Hematocrit 24.7%
Leukocytes 53,900/mm3
Platelets 131,000/mm3
AST (aspartate aminotransferase) 1,208 u/L
ALT (alanine aminotransferase) 844 u/L
Total bilirubin 2.13 mg/dL
Direct bilirubin 1.75 mg/dL
Indirect bilirubin 0.38 mg/dL
Gamma glutamyl transferase 542 U/L
leptospirosis, toxoplasmosis, HTLV1, HTLV2, and viral 
hepatitis types A, B, C were investigated, and ELISA method 
was used for all research; for mononucleosis, another two 
samples were collected, and the method used was Hoff and 
Bauer; for leishmaniasis and paracoccidioidomycosis the tech-
nique of complement fi xation reaction was used; for Chagas 
disease, immunoﬂ uorescence was used; for cytomegalovirus, 
chemiluminescence was used. All results were negative. When 
researching HIV (human immunodefi ciency virus) 1 and 2, 
at least two samples were collected at different times with 
microparticle enzyme immunoassay (MEIA), and all were 
negative. PPD (Purifi ed Protein Derivative of tubercle bacilli) 
was non-reactive, as shown in Table 2. Lymph node biopsy 
revealed diffuse proliferation of histiocytic cells with mature 
Table 2. Search for the infectious agent
Brucellosis Non-reagent  Enzyme immunoassay
Leptospirosis Non-reagent Enzyme immunoassay
Toxoplasmosis Non-reagent Enzyme immunoassay
HTLV-1, HTLV-2 Non-reagent Enzyme immunoassay
Viral hepatitis types A, B, C Non-reagent Enzyme immunoassay
Mononucleosis - two samples Non-reagent Monotest Hoff-Bauer
Leishmaniasis Non-reagent Complement fixation reaction
Paracoccidioidomycosis Non-reagent Complement fixation reaction
Chagas disease Non-reagent Immunofluorescence
Cytomegalovirus Non-reagent Chemiluminescence
HIV 1 e 2 – two samples with a 3-month-interval Non-reagent Microparticle enzyme immunoassay
PPD Non-reactive
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disease, antinuclear factor (ANF), anti-native DNA, anti-
SSA/Ro, RNP - antigen extracted from nucleus, anti-SM 
(anti-smith), anti-endomysial, SSB (La) - antigen extracted
from nucleus; all were non-reactive. Total complement 385 mg/dL,
complement C3 175 mg/dL, complement C4 43.9 mg/dL, 
as it is shown in Table 5. Cell immunity was evaluated at 
CD4 = 250 cells/mm3, CD8 = 2,340 mm3, as shown in Table 6. 
The abdominal ultrasound showed hepatosplenomegaly. 
Table 4. Laboratory from the second hospitalization
Red blood cell 4,950 million/mm3
Hemoglobin 11.6g/dL
Hematocrit 35%
Leukocytes 18,000/mm3
Platelets 277,000/mm3
LDH 942 U/L
AP 72 UI
AST 107 U/L
ALT 69 U/L
GGT 33 U/L
Creatinine 0.8 mg/dL
BUN 24 mg/dL
K 4.0 mEq/L
Na 140 mEq/L
Albumin 3.2 g/dL
Table 3. Results of the examinations through lymph 
node tissue histochemistry
Antigen Result
Antigen ki-67 Positive (++/+++) 
(clone MIB-1) in follicular areas
CD30 (clone Ber-H2) Negative
Epithelial membrane Focal positive in 
antigen (EMA)  permeate [R1] plasmocyte
Leukocyte common Positive
antigen (LCA-CD45)
CD15 (granulocyte  Negative
associated antigen) 
Oncoprotein Bcl-2 Negative follicular areas
CD3 (monoclonal antibody –  Positive interfollicular
T lymphocyte marker) lymphoid cells
CD20 (monoclonal antibody  Positive in follicular
L26 – B lymphocyte marker) lymphoid cells
Table 5. Investigation of autoimmune disease
Anti-nuclear factor (ANF) Non-reagent
Anti-native DNA Non-reagent
Anti-SSA/RO Non-reagent
RNP - antigen extracted from nucleus Non-reagent
Anti-SM Non-reagent
Anti-endomysial Non-reagent
SSB (La) - antigen extracted from nucleus Non-reagent
Total complement 385 mg/dL
Complement C3 175 mg/dL
Complement C4 43,9 mg/dL
Table 6. Evaluation of cell immunity
CD4 250 cells/mm3
CD8 2,340 cells/mm3
Figure 1: Lymph node slice presenting preserved lymphoid 
follicle, surrounded by numerous histiocytes. (HE stain, 100X).
Figure 2: Presence of numerous histiocyte cells, with vesicular 
nucleus, and some degenerating cells. Small and medium-
sized lymphocytes can also be observed. (HE stain, 400X).
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All tests were performed at Laboratório da Santa Casa de Mis-
ericórdia de Santos (Figures 3, 4 and 5).
An antibiotic therapy for lung focus was initiated 
with moxiﬂ oxacin (400 mg/day for three days), with 
no improvement. The patient evolved for lung focused 
sepsis, and the medication was changed for cefepime 
(4 g/day) and vancomycin (2 g/day).
Considering Kikuchi-Fujimoto disease as the pathological 
basis, the use of non-hormonal anti-inﬂ ammatory piroxicam 
(40 mg/day for fi ve days) was initiated. There was no response 
to the anti-inﬂ ammatory, and although the patient remained 
severely ill, renal function remained preserved (creatinine 
0.8 mg/dL; urea 34 mg/dL). Due to the case’s severity, a treat-
ment with prednisone (60 mg/day for 15 days) was adopted, 
having good clinical response. Once the corticosteroid dose 
started to be reducing (20 mg of prednisone/day), the patient 
worsened and evolved to acute renal failure, with serum levels 
of creatinine at 72 mg/dL; BUN 231 mg/dL; Na 141 mEq/L; 
and K 6.1 mEq/L. On the ultrasound scan, the kidneys ap-
peared to have acute parenchymatous nephropathy. Four ses-
sions of hemodialysis were performed.
With prednisone’s dose as it was previously (60 mg/day), the 
patient had excellent improvement with a regression of the syn-
drome. After 64 days of outpatient treatment, he was discharged 
from the hospital, keeping the corticoid therapy. As he evolved, 
renal and liver biopsy revealed: tubular degenerative change, and 
mild chronic hepatic inﬂ ammatory activity, eliminating the di-
agnosis of autoimmune hepatitis. Currently the patient main-
tains proteinuria of 0.27 g/24 h, and therefore receives captopril 
(25 mg/day), and prednisone (20 mg/day). The patient has had 
the disease inactive for three years.
DISCUSSION
Historically, it has been reported that KFD affects women 
more than men in a ratio of approximately four to one.1 Re-
cent reports seem to indicate that the female preponderance 
was overemphasized in the past, and that the actual ratio is 
closer to 1:1.5 And KFD has been reported to have occurred 
in a parent and a child.6
This disease’s pathogenesis is still unknown. Several 
etiologies have been reported. Cases of KFD have been de-
scribed as being associated with infections by Epstein-Barr 
virus, cytomegalovirus, herpes simplex type 6 and 8, HT-
LV-1, HIV, parvovirus type B, parainﬂ uenza, paramyxovirus, 
Toxoplasma, Yersinia enterocolitica, brucellosis, the mumps 
virus, Mycobacterium szulgai and Bartonella henselae.
The hypothesis of a casual relation between viral infectious 
agents and KFD is coherent due to a raise found in the levels 
of interferon alpha and 2-5 oligoadenilate synthetase.1 There 
are also reports of raise in the serum level of interferon gamma 
and interleukin-6 in patients with KFD. However, the attempts 
to identify a specifi c etiologic agent through culture, serol-
ogy, polymerase chain reaction (PCR), and hybridization tech-
niques have all failed.1,7 A strong autoimmune component of 
the disease, which has been observed2 and is also our case, could 
be related to the etiology. Thus all the cultures and serologies 
are negative, and through remission of the disease with high 
dose of corticosteroids. In the case in study, cell immune defi -
ciency has been reported due to low counting of lymphocyte 
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Figure 3: Immunohistochemical examination. Nuclear 
immunoexpression in lymphoid cells from paracortical area. 
(CD3, 400X).
Figure 4: Immunohistochemical examination. Immunoexpres-
sion of B lymphocyte in the lymphoid follicle (CD20, 100X).
Figure 5: Lymph node immunohistochemical examination. 
Great expression in histiocyte cells present on the display 
(CD68, 400X).
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CD4 (CD4 = 250 cells/mm3). The existence of lymphocyte and 
histiocyte cells suggests hyperimmune lymphadenitis reactive 
to several infectious, irritative, toxic, and neoplasic factors.2 
A change in cell immunity (T lymphocyte) with delayed hy-
persensitivity to some antigens was also observed. There are re-
ports on the association of Kikuchi-Fujimoto disease with sys-
temic lupus erythematosus (SLE), Still’s disease, Hashimoto’s 
thyroiditis, subacute lymphocyte thyroiditis, silicone implants, 
hepatic transplant,1 polymyositis, and rheumatoid arthritis.7 In 
our case, the antibodies present in the autoimmune diseases’ 
diagnosis were negative. What can also be discarded is lupus 
nephritis, since the tubular lesion seen in this patient’s optical 
microscopy (OM) is non-specifi c, and none deposits suggest-
ing lupus nephritis, were found in the immunoﬂ uorescence, 
nor a glomerular lesion in the OM.
Clinical manifestations of KFD frequently occur as acute 
or subacute forms, which last for periods of 2 to 3 weeks. 
The most common form of presentation is lymphaden-
opathy, primary cervical (74% to 90% of the cases) or su-
praclavicular. Adenopathies typically measure less than 3 cm 
in diameter, present a fi rm consistency and are sometimes 
painful upon palpation. Generalized lymphadenopathy 
occurs in a minority (5%) of cases.8
The disease courses with fever from 30% to 50% of cases, 
usually of low-grade, associated with symptoms of upper res-
piratory tract. Symptoms such as weight loss, nausea, vomit-
ing, sore throat, and night sweat are not common, and when 
they occur, they are related to extranodal involvement.5,6,7,9 
Recurrence of the disease is about 3% of cases in a period of 
12 to 18 years after the fi rst episode.
Because of this, long-term follow-up evaluation should 
be performed due to disease recurrence and to the possibil-
ity of SLE (systemic lupus erythematosus) development.8
There are atypical systemic manifestations such as panu-
veitis with impairment of visual acuity,10 arthritis,11 four cases 
of aseptic meningitis, amigdalitis12 and cryptogenic organiz-
ing pneumonia.13 Mortality is rarely found in KFD, but there 
have been three cases due to the disease, such as a 38-year-old 
woman with acute heart failure, in whose necropsy multiple 
focuses of cardiac necrosis were found; there has been another 
case of a 19-month-old child who died of febrile syndrome, 
and whose necropsy revealed a clinical picture compatible 
with extranodal and nodal KFD;14 fi nally, there has been a case 
of KFD death in a patient who had received a transplant.12
The defi nitive diagnosis of KFD is made through lymph 
node excision biopsy and histologic examination. There are 
several classic histologic features of KFD. The affected lymph 
nodes have patchy necrotizing regions (the degree of necrosis 
varies widely among patients), mainly in the paracortical areas. 
They often contain well-circumscribed areas of eosinophilic 
fi brinoid material with a substantial degree of karyorrhexis. 
Transformed lymphocytes (immunoblasts) may surround the 
necrotic areas, creating a characteristic mottled appearance at 
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low magnifi cation. Nuclear debris is evenly scattered through-
out the necrotic areas and is associated with atypical mononu-
clear cells, which may be macrophages phagocytosing the de-
bris.14 It has been reported that the lesional cells extended into 
the perinodal fi broadipose tissue.15 The histological change in 
KFD has been classifi ed into three stages: an early prolifera-
tive stage, an intermediate phagocytic stage, and a full-blown 
post necrotic or xanthomatous stage. During the proliferative 
stage, CD116 and CDIIc positive histiocytes predominant are 
accompanied by numerous atypical lymphocytes, which are 
primarily CD4+ T helper cells. In contrast, CD8+ suppressor 
T lymphocytes are the most predominant cells in the post-
necrotic stage.16 In a retrospective study of 1,724 lymph node 
biopsy samples, KFD was found in 36 cases.17
As reported in the literature, the lymph nodes immuno-
histochemistry were characterized by numerous CD20-pos-
itive B-cell displayed in primary and secondary reactive lym-
phoid follicles, often surrounded by prominent B-cell rich 
mantle zones. In contrast, most cells within the necrotizing 
foci were large CD68-positive phagocytic macrophages and 
plasmacytoid dendritic cells, with scattered medium to large 
CD3-positive T-cells, and relatively few scattered medium to 
large CD20-positive B-cells.18
Radiographic fi ndings specifi c to KFD have not been estab-
lished, and reports of KFD in the medical literature have largely 
focused on the disease pathology. Chest radiography should 
be included in the diagnostic evaluation to eliminate the pos-
sibility of malignancy or tuberculosis. CT and ultrasonography 
scans are common and often helpful before obtaining a bi-
opsy specimen. Ultrasonography scan frequently shows lymph 
nodes with a hypoechoic center and a hyperechoic rim.11,12 
CT fi ndings generally mimic those of lymphoma; however, 
lymph nodes in patients with KFD are not as large as those in 
patients with lymphoma. There are no specifi c assays available 
to confi rm the diagnosis of KFD.14
The radiographic diagnosis of KFD is broad and includes 
Hodgkin and non-Hodgkin disease, metastatic tumor, tuber-
culosis, nontuberculous mycobacterial infection, SLE, human 
immunodefi ciency virus infection, infectious mononucleosis, 
cat-scratch disease, mucocutaneous lymph node syndrome 
(Kawasaki disease), and toxoplasmosis. In one series, 29% of 
patients with KFD were initially misdiagnosed as having Hodg-
kin or non-Hodgkin disease.14
The differential diagnosis of a slow-growing neck mass is 
broad and includes malignant lymphoma, systemic lupus ery-
thematosus (SLE), Hodgkin disease, toxoplasmosis, metastatic 
carcinoma, infectious mononucleosis, acquired immunodefi -
ciency syndrome, cat-scratch disease, and angioimmunoblastic 
lymphadenopathy.14 KFD is different from lymphoma, espe-
cially in early stages, in which there are few necrosis zones and 
also immunoblasts originating among nuclear debris. Immu-
nophenotyping constitutes a process valuable for distinguish-
ing these two entities.19
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There are some characteristics, such as gender and age, as 
well as histological alterations, that KFD and SLE have in com-
mon, some authors considering the former to be a lupus-like 
syndrome. It has been proposed that KFD is a manifestation 
of, or evolves to, SLE, justifying the surveillance of KFD pa-
tients using immunological studies such as ANF (antinuclear 
factor) testing. Patients can present positivity for ANF, anti 
ribonucleoprotein, anti-DNA and lupus anticoagulant. Other 
autoimmune conditions, such as antiphospholipid antibody 
syndrome, polymyositis, Still’s disease, uveitis, scleroderma, 
thyroiditis, pulmonary hemorrhage and interstitial lung dis-
ease, can be associated with KFD.8
KFD and lymph nodal tuberculosis (LTB) are commonly 
mistaken. There are cases in the literature described with 
LTB diagnosis before the anatomopathological examina-
tion.12 There is also another case in which the patient re-
ceived treatment for Wegener’s granulomatosis.8 That is why 
the etiologic diagnosis is important, in order to avoid long 
and expensive treatment.
There is no effective treatment. Patients with more severe 
or persistent symptoms have been treated with corticoster-
oids.8 In our case, corticoid therapy with prednisone has had 
signifi cant importance, for it revealed transitory relation with 
symptom reduction. With the remission of prednisone, the 
patient has shown a worse KFD picture and has presented an 
atypical systemic manifestation, which has not been reported 
in the literature for this disease: acute kidney failure (AKF). 
Because suspicion that AKF had relation to the disease was 
arisen, immunosuppresant doses were retaken, thus immedi-
ately improving KFD and leading to remission of nephropa-
thy, revealing it to be dependent on prednisone dosage. The 
new attempt of reducing the doses of corticoid therapy had 
success. For the authors, remains the impression that the AKF 
appeared in a moment when KFD had stronger symptoms 
and when adequate treatment of Kikuchi disease reduced kid-
ney failure. All this leads us to thinking that besides turbidity, 
arthralgia, myalgia, pericarditis, and hepatitis, acute kidney 
failure is another manifestation of the disease.
In conclusion, KFD usually occurs as acute or sub-
acute, with auto limited evolution; an important differen-
tial diagnosis must be done with lymphoma, which was the 
main differential diagnosis in the case reported. Although 
it might still be related to autoimmune disease, so far there 
has not been a report of renal failure in literature. With 
that being said, nephropathy associated with HIV can be 
discarded, since the patient is HIV-negative and no typi-
cal lesion has been identifi ed. Despite the patient having 
presented a series of irregularities during the disease’s evo-
lution, the possibility of interstitial nephritis induced by 
drugs has not been confi rmed, since that was not evident 
in the renal biopsy. However, the patient’s lesion was non-
specifi c, and although it was atypical, it could have been 
induced by drugs, by any irregularity, or it could even have 
resulted from Kikuchi-Fujimoto disease itself. The disease 
induced by drugs usually evolves in a benign way, with ex-
tranodal impairment and severe systemic manifestations, 
which were found in our patient. For the cases in which 
there is no auto limited evolution, it may be necessary to 
have corticoid therapy in immunosuppresant dosage, de-
pending on how severe it is. Such strategy was successfully 
adopted in the case under study.
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